サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629267

血漿療法の世界市場：製品タイプ別、供給源別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Plasma Therapy Market, By Product Type, By Source, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 393 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血漿療法の世界市場：製品タイプ別、供給源別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年12月30日
発行: AnalystView Market Insights
ページ情報: 英文 393 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

世界の血漿療法の市場規模は、2023年に4億6,889万米ドルとなり、2024年～2032年に14.5%のCAGRで拡大すると予測されています。

血漿療法市場：市場力学

自己免疫疾患の増加が血漿療法市場の成長を牽引

血漿療法の需要は、世界的に数百万人が罹患している自己免疫疾患の有病率の上昇により増加しています。American Autoimmune Related Diseases Associationによると、5,000万人近くのアメリカ人が自己免疫疾患に苦しんでおり、関節リウマチやループスのような疾患がより一般的になっています。免疫グロブリンや凝固因子などの血漿由来療法は、免疫系を増強し、臓器障害を予防することにより、これらの疾患を管理する上で極めて重要です。さらに、血漿分画技術の進歩や血漿提供プログラムの増加も、市場の拡大を後押ししています。自己免疫疾患は世界的に増加すると予測されており、血漿療法市場は今後数年間で大きな成長が見込まれます。

血漿療法市場：主要洞察

リサーチアナリストの分析によると、世界市場は予測期間（2024年～2032年）に約14.5%のCAGRで毎年成長すると推定されます。

製品タイプ別では、ピュアPRPが2023年に最大の市場シェアを示すと予測されています。

供給源別では、自己血漿が2023年の主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

血漿療法市場：セグメンテーション分析：

世界の血漿療法市場は、製品タイプ、供給源、用途、エンドユーザー、地域に基づいて区分されます。

市場は製品タイプ別により4つに分類され、ピュアPRP（多血小板血漿）、白血球豊富PRP、純多血小板フィブリン、白血球豊富フィブリンです。ピュアPRPは再生医療と美容に広く使用されているため市場をリードしており、次いで白血球豊富PRPが治癒特性を高めることで知られています。純多血小板フィブリンがこれに続き、白血球豊富フィブリンは特定の治療におけるニッチな選択肢のままです。

市場は、供給源別に2つのカテゴリーに分けられ、自己血漿と同種血漿です。自己血漿は免疫反応のリスクが低いためリードしており、ほとんどの治療用途で好まれています。同種血漿は、特定の臨床治療に使用されますが、適合性の必要性や免疫関連合併症の可能性により制限されます。

血漿療法市場：地理的洞察

血漿療法市場は地域差が大きく、北米が市場をリードしていますが、これは高度なヘルスケアインフラと血漿由来の治療に対する高い需要が背景にあります。米国は、その広範な血漿提供ネットワークと自己免疫疾患を患う人口の多さから、大きな貢献をしています。ドイツや英国のような国々では、血漿収集システムが確立されており、血漿療法による慢性疾患の治療に注目が集まっています。アジア太平洋は、特に中国やインドのような国々で急速な成長を遂げており、医療投資の増加と医療意識の高まりが血漿療法の採用を拡大しています。ラテンアメリカと中東・アフリカでは、ヘルスケアへのアクセスが向上し、血漿療法の利点に対する認識が高まっているため、需要が伸びています。血漿提供システムの改善に向けた政府の取り組みが、これらの地域での市場拡大をさらに促進すると期待されています。

血漿療法市場：競合情勢

血漿療法市場は競争が激しく、主要企業は製品ポートフォリオの拡充と血漿収集ネットワークの強化に注力しています。同市場の主要企業には、Grifols、CSL Behring、Octapharma、Kedrion Biopharma、Baxter Internationalなどがあり、血漿由来療法分野を支配しています。これらの企業は、免疫グロブリン、アルブミン、凝固因子など、血漿療法の需要増加に対応するため、新しく改良された血漿由来製品を導入する研究開発に多額の投資を行っています。さらに、世界な展開と生産能力の強化を目指す企業にとって、戦略的提携や買収は一般的です。例えば、GrifolsとCSL Behringは買収と地域拡大を通じてその地位を強化しています。さらに、FDAやEMAなどの規制機関は血漿療法の安全性と有効性を確保する上で重要な役割を果たしており、市場における技術革新と品質管理を重視する競合環境を促進しています。

目次

第1章 血漿療法市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 血漿療法の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 血漿療法業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 血漿療法市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 血漿療法市場情勢

  • 血漿療法市場シェア分析：2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 血漿療法市場：製品タイプ別

  • 概要
    • 製品タイプ別のセグメントシェア分析
    • ピュアPRP（多血小板血漿）
    • 白血球豊富PRP
    • 純血小板リッチフィブリ
    • 白血球豊富フィブリン

第8章 血漿療法市場：供給源別

  • 概要
    • 供給源別のセグメントシェア分析
    • 自己血漿
    • 同種血漿

第9章 血漿療法市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 整形外科
    • 皮膚科
    • 歯科
    • 心臓病学

第10章 血漿療法市場：エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • クリニック
    • 研究機関

第11章 血漿療法市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：血漿療法業界

  • 競合ダッシュボード
    • 競合ベンチマーキング
    • 競合ポジショニング
  • 企業プロファイル
    • Arthrex, Inc.
    • Johnson &Johnson Services, Inc.
    • Thermo Fisher Scientific Inc.
    • EmCyte Corporation
    • Zimmer Biomet Holdings, Inc.
    • Terumo Corporation
    • Regen Lab SA
    • BioLife Plasma Services
    • Cesca Therapeutics Inc.
    • Aesthetic Medical International Holdings Group Ltd.
    • Dr. PRP America LLC
    • AdiStem Ltd.
    • Vivostat A/S
    • Estar Medical Ltd.
    • Stryker Corporation
    • Plasmagen BioSciences Pvt. Ltd.
    • その他

第13章 アナリストの全方位展望

目次
Product Code: ANV4554

REPORT HIGHLIGHT

Plasma Therapy Market size was valued at USD 468.89 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The Plasma Therapy Market involves using plasma-derived products, including immunoglobulins, clotting factors, and albumin, for treating various medical conditions, such as immune deficiencies, bleeding disorders, and autoimmune diseases. The growing demand for plasma therapy is spurred by an increasing prevalence of chronic conditions, with the World Health Organization reporting that over 350 million people worldwide suffer from autoimmune diseases. Additionally, the rising number of trauma cases and surgical interventions requiring plasma-based treatments fuel market growth. However, the market faces challenges such as the high cost of plasma collection and processing, along with limited donor availability. Despite these challenges, opportunities are emerging with advancements in plasma fractionation technology, which allows for higher yields of therapeutic proteins, and the expansion of plasma donation programs in developing regions. Furthermore, the growing adoption of plasma therapies in the treatment of COVID-19 and other infectious diseases is contributing to market expansion.

Plasma Therapy Market- Market Dynamics

Rising Prevalence of Autoimmune Diseases Drives Growth in the Plasma Therapy Market

The demand for plasma therapy is increasing due to the rising prevalence of autoimmune diseases, which affect millions globally. According to the American Autoimmune Related Diseases Association, nearly 50 million Americans suffer from autoimmune disorders, with conditions like rheumatoid arthritis and lupus becoming more common. Plasma-derived therapies, such as immunoglobulins and clotting factors, are critical in managing these diseases by boosting the immune system and preventing organ damage. Additionally, ongoing advancements in plasma fractionation technology and the growing availability of plasma donation programs are further supporting the expansion of the market. With autoimmune diseases projected to rise globally, the market for plasma therapies is expected to experience significant growth in the coming years.

Plasma Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on product type segmentation, Pure PRP was predicted to show maximum market share in the year 2023

Based on Source segmentation, Autologous Plasma was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasma Therapy Market- Segmentation Analysis:

The Global Plasma Therapy Market is segmented based on Product Type, Source, Application, End-User, and Region.

The market is divided into four categories based on product type: Pure PRP (Platelet-Rich Plasma), Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-rich Fibrin. Pure PRP leads the market due to its widespread use in regenerative medicine and aesthetics, followed by Leukocyte-Rich PRP, known for its enhanced healing properties. Pure Platelet-Rich Fibrin follows, with Leukocyte-rich Fibrin remaining a niche option in specific treatments.

The market is divided into two categories based on Source: Autologous Plasma and Allogeneic Plasma. Autologous plasma leads due to its lower risk of immune reactions and is preferred in most therapeutic applications. Allogeneic plasma follows, used in certain clinical treatments but limited by the need for compatibility and the potential for immune-related complications.

Plasma Therapy Market- Geographical Insights

The Plasma Therapy Market shows substantial geographical variation, with North America leading the market, driven by advanced healthcare infrastructure and high demand for plasma-derived therapies. The United States is a major contributor due to its extensive plasma donation network and a large population suffering from autoimmune diseases. Europe follows closely, with countries like Germany and the UK having well-established plasma collection systems and a growing focus on treating chronic conditions through plasma therapies. The Asia-Pacific region is experiencing rapid growth, particularly in countries like China and India, where increasing healthcare investments and rising healthcare awareness are expanding the adoption of plasma therapies. Latin America and the Middle East & Africa are witnessing growing demand due to rising healthcare access and increasing awareness about plasma therapy benefits. Government initiatives to improve plasma donation systems are expected to further drive market expansion in these regions.

Plasma Therapy Market- Competitive Landscape:

The Plasma Therapy Market is highly competitive, with key players focusing on expanding their product portfolios and enhancing plasma collection networks. Major companies in the market include Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and Baxter International, which dominate the plasma-derived therapies sector. These companies are investing heavily in research and development to introduce new and improved plasma-derived products, including immunoglobulins, albumin, and clotting factors, to cater to the increasing demand for plasma therapies. Additionally, strategic collaborations and acquisitions are common as companies seek to expand their global reach and enhance production capabilities. For example, Grifols and CSL Behring have strengthened their positions through acquisition and regional expansion. Moreover, regulatory bodies like the FDA and EMA play a crucial role in ensuring the safety and efficacy of plasma therapies, fostering a competitive environment that emphasizes innovation and quality control in the market.

Recent Developments:

In October 2021, BioLife Plasma Services opened a new plasma center in Worcester, United States, to address the increasing demand for plasma-derived therapies, enhancing their capacity to collect and provide plasma for treatments.

In August 2021, Biotest AG opened its sixth plasma collection center in the Czech Republic, aiming to secure a long-term plasma supply and meet the growing demand for plasma-derived therapies through expanded collection capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arthrex, Inc.
  • Johnson & Johnson Services, Inc.
  • Thermo Fisher Scientific Inc.
  • EmCyte Corporation
  • Zimmer Biomet Holdings, Inc.
  • Terumo Corporation
  • Regen Lab SA
  • BioLife Plasma Services
  • Cesca Therapeutics Inc.
  • Aesthetic Medical International Holdings Group Ltd.
  • Dr. PRP America LLC
  • AdiStem Ltd.
  • Vivostat A/S
  • Estar Medical Ltd.
  • Stryker Corporation
  • Plasmagen BioSciences Pvt. Ltd.
  • Others

GLOBAL PLASMA THERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pure PRP (Platelet-Rich Plasma)
  • Leukocyte-Rich PRP
  • Pure Platelet-Rich Fibrin
  • Leukocyte-rich Fibrin

GLOBAL PLASMA THERAPY MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Plasma
  • Allogeneic Plasma

GLOBAL PLASMA THERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Orthopedics
  • Dermatology
  • Dentistry
  • Cardiology

GLOBAL PLASMA THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Research Institutes

GLOBAL PLASMA THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Plasma Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Plasma Therapy Market Snippet by Product Type
    • 2.1.2. Plasma Therapy Market Snippet by Source
    • 2.1.3. Plasma Therapy Market Snippet by Application
    • 2.1.4. Plasma Therapy Market Snippet by End-User
    • 2.1.5. Plasma Therapy Market Snippet by Country
    • 2.1.6. Plasma Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Therapy Key Market Trends

  • 3.1. Plasma Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Plasma Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Plasma Therapy Market Opportunities
  • 3.4. Plasma Therapy Market Future Trends

4. Plasma Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Plasma Therapy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Plasma Therapy Market Landscape

  • 6.1. Plasma Therapy Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Plasma Therapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Pure PRP (Platelet-Rich Plasma)
    • 7.1.3. Leukocyte-Rich PRP
    • 7.1.4. Pure Platelet-Rich Fibrin
    • 7.1.5. Leukocyte-rich Fibrin

8. Plasma Therapy Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2. Autologous Plasma
    • 8.1.3. Allogeneic Plasma

9. Plasma Therapy Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Orthopedics
    • 9.1.3. Dermatology
    • 9.1.4. Dentistry
    • 9.1.5. Cardiology

10. Plasma Therapy Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Research Institutes

11. Plasma Therapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Plasma Therapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Plasma Therapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Plasma Therapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Plasma Therapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Plasma Therapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Plasma Therapy Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arthrex, Inc.
    • 12.2.2. Johnson & Johnson Services, Inc.
    • 12.2.3. Thermo Fisher Scientific Inc.
    • 12.2.4. EmCyte Corporation
    • 12.2.5. Zimmer Biomet Holdings, Inc.
    • 12.2.6. Terumo Corporation
    • 12.2.7. Regen Lab SA
    • 12.2.8. BioLife Plasma Services
    • 12.2.9. Cesca Therapeutics Inc.
    • 12.2.10. Aesthetic Medical International Holdings Group Ltd.
    • 12.2.11. Dr. PRP America LLC
    • 12.2.12. AdiStem Ltd.
    • 12.2.13. Vivostat A/S
    • 12.2.14. Estar Medical Ltd.
    • 12.2.15. Stryker Corporation
    • 12.2.16. Plasmagen BioSciences Pvt. Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us